Kadmon Holdings Inc (NASDAQ: KDMN), a New York, New York, company, fell to close at $8.73 Friday after losing $0.09 (1.02%) on volume of 9,532,102 shares. The stock ranged from a high of $8.86 to a low of $8.73 while Kadmon’s market cap now stands at $1,504,618,669.
About Kadmon Holdings Inc
Kadmon is a clinical-stage biopharmaceutical company that discovers, develops and delivers transformative therapies for unmet medical needs. Its clinical pipeline includes treatments for immune and fibrotic diseases as well as immuno-oncology therapies.